Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
23 Results for "
ferric reducing
" in MedChemExpress (MCE) Product Catalog:
Products (23)
23 Results for "ferric reducing" in MCE Product Catalog:
Synonyms: L-Cysteinylglycine; Cys-Gly; H-Cys-Gly-OH
Cat. No.: HY-W035520
CAS No.: 35369-53-0
Target:
HBED dihydrochloride is an iron-chelating antioxidant. HBED dihydrochloride chelates ferrous iron, promotes its oxidation to ferric iron, and blocks superoxide-driven ferric iron reduction, preventing Haber-Weiss/Fenton hydroxyl radical production. HBED dihydrochloride donates H/electrons, undergoes protonation, reduces radical cations, and forms phenoxyl radicals. HBED dihydrochloride exerts cytoprotective effects against peroxide-induced lung fibroblast injury. HBED dihydrochloride crosses the blood-brain barrier and mitochondrial membrane, exhibits iron affinity/selectivity, and induces iron clearance in iron-loaded monkeys. HBED dihydrochloride reduces hippocampal AQP4, microgliosis, oxidative stress, cerebral edema, and hippocampal swelling, and improves motor function/recovery after traumatic brain injury. HBED dihydrochloride can be used in research on iron overload and traumatic brain injury (TBI) .
Cat. No.: HY-N2307A
CAS No.: 54383-28-7
Synonyms: (+)-Lirinidine
Category:
Alkaloids Plant Monophenols Nelumbo nucifera Gaertn. Extract Phenols Nymphaeaceae Extract Disease Research Fields Isoquinoline Alkaloids Cancer
Target:
Target:
Research Areas:
HBED is an iron-chelating antioxidant. HBED chelates ferrous iron, promotes its oxidation to ferric iron, and blocks superoxide-driven ferric iron reduction, preventing Haber-Weiss/Fenton hydroxyl radical production. HBED donates H/electrons, undergoes protonation, reduces radical cations, and forms phenoxyl radicals. HBED exerts cytoprotective effects against peroxide-induced lung fibroblast injury. HBED crosses the blood-brain barrier and mitochondrial membrane, exhibits iron affinity/selectivity, and induces iron clearance in iron-loaded monkeys. HBED reduces hippocampal AQP4, microgliosis, oxidative stress, cerebral edema, and hippocampal swelling, and improves motor function/recovery after traumatic brain injury. HBED can be used in research on iron overload and traumatic brain injury (TBI) .
Cat. No.: HY-W068771
CAS No.: 943-89-5
Target:
Cat. No.: HY-N9588
CAS No.: 22860-72-6
Target:
Cat. No.: HY-174867
CAS No.: 3091513-13-9
Target:
Research Areas:
AY-4 (Compound AY-4) is an efficient PROTAC degrader targeting FTH1 (Kd = 3.17 nM). AY-4 effectively upregulates the levels of ferrous (Fe 2+) and ferric (Fe 3+) ions in cells. AY-4 is a potential anticancer candidate compound that regulates iron homeostasis through ferritin degradation and enhances the efficacy of existing drugs. AY-4 can effectively reduce the level of FTH1 in breast cancer cells (Pink: FTH1 ligand AY-2 (HY-174871); Blue: E3 ligand Pomalidomide (HY-10984); Black: Linker, Pomalidomide-PEG3-acid (HY-174872)) .
Cat. No.: HY-113110R
CAS No.: 19246-18-5
Synonyms: L-Cysteinylglycine (Standard); Cys-Gly (Standard); H-Cys-Gly-OH (Standard)
Cat. No.: HY-N10770
CAS No.: 1221762-70-4
Target:
Cat. No.: HY-W068771R
CAS No.: 943-89-5
Target:
Cat. No.: HY-N21600
CAS No.: 1619976-98-5
Category:
Flavonols Plant Flavonoids Cyperaceae Extract Eleocharis dulcis (Burm. f.) Trin. ex Hensch. Extract
Target:
Category:
Plant Artemisia tridentata Nutt. Extract Terpenoids Sesquiterpenes Compositae/Asteraceae Extract
Target:
Cat. No.: HY-N7648A
CAS No.: 54749-97-2
Synonyms: Atherospermine hydrochloride
Target:
Cat. No.: HY-184638
APTS Fe2O3 Nanoparticles (Aminated ferric oxide magnetic nanoparticles) are magnetic nanomaterials modified with amino functional groups using APTS. This material consists of a ferric oxide (Fe3O4) nanoparticle core and an amino (-NH2) surface modification layer. The aminated surface helps improve the biocompatibility of the nanoparticles and reduce cytotoxicity. The amino functional groups can be further chemically modified for coupling with biomolecules such as drugs, proteins, and nucleic acids. The amino functional groups undergo protonation at different pH values, resulting in different surface charges on the nanoparticles in different pH environments.
Cat. No.: HY-189530
CAS No.: 96460-77-4
Target:
Research Areas:
Antioxidant agent-25 is an antioxidant that scavenges DPPH free radicals and reduces ferric ions. Antioxidant agent-25 has antifungal activity, inhibiting dermatophytes and Candida albicans. Antioxidant agent-25 has antiproliferative activity, inhibiting cancer cells. Antioxidant agent-25 is cytotoxic to normal kidney cells. Antioxidant agent-25 can be used in research on dermatomycoses, leukemia, and melanoma .
Cat. No.: HY-189722
Research Areas:
Multi-target kinase-IN-13 is a multi-target enzyme inhibitor and antioxidant. Multi-target kinase-IN-13 inhibits α-amylase, α-glucosidase, and aldose reductase, with IC50 values of 6.71, 4.78, and 4.04 µg/mL, respectively, thereby slowing starch digestion, reducing intestinal glucose absorption, and inhibiting the polyol pathway. Multi-target kinase-IN-13 scavenges DPPH, ABTS, and NO free radicals and exhibits antioxidant capacity and ferric reducing ability. Multi-target kinase-IN-13 can be used in studies related to diabetes and antioxidation .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
